Lyophilised beads – Key benefits:

The future of Point of Care testing

Point of Care testing offers the accuracy of laboratory based testing but delivers results in minutes or hours rather than days.

Lyophilising the molecular and enzymatic reagents within Point of care devices is challenging, traditionally requiring them to be dispensed within the device and then lyophilising in-situ.  However this requires a freeze-drying capacity significantly larger than necessary, simply to accommodate the volume of cartridges.

Beads provide a perfect solution for lyophilising reagents for use in Point of Care platforms. A single accurate dose of the reagent is lyophilised in a durable sphere which can then be sub-assembled into cartridges at a later stage in the manufacturing process.

This provides a far more efficient and cost-effective use of freeze-drying capacity, resulting in a throughput uplift of up to 1000 times the volumes achieved by lyophilising in-situ

Assured supply at scale

As an established lyophilisation specialist we have made a significant investment in order to increase our  bead manufacturing capacity to around 5 million beads per month, dependent upon size and formulation.

Together with our ISO 13485 certification, ISO 17025 accreditation, FDA registration and state-of-the-art facilities this means mean that you can rely on quality assured continuous supply route; whether you are in the early stages of development or looking for a fast and flexible option to scale up manufacturing.